Academic Profile at a Glance

• Professor of Pathology and Vice-Chair of Research within the Robert J. Tomsich Pathology & Laboratory Medicine Institute within the Cleveland Clinic
• World-renowned molecular pathologist and researcher with a successful track record and a focused interest in the diagnosis and treatment of sarcomas
• Author of over 100 peer-reviewed journal articles and author of numerous reviews and book chapters on sarcomas
• Co- authored the WHO Classification of Tumors of Bone and Soft Tissue Tumors (sarcomas) (2002 and 2012)
• Played key roles in the identification of therapeutic targets in gastrointestinal stromal tumor (GIST) and dermatofibrosarcoma protuberans – resulting in FDA approval of imatinib mesylate - Gleevec as first line medical therapy in these diseases

• Pitfalls in Diagnostic Pathology: GI, Pulmonary, Endocrine and Soft Tissue

Past Lectures

• The Classificatoin of Benign Nerve Sheath Tumors (06/23/2016)
• Soft Tissue Lesions of Skin and Subcutis (06/23/2016)
• Abdominal-Pelvic-Retroperitoneal Sarcomas (06/22/2016)
• Spindle Cell Sarcomas of the Deep Soft Tissues (06/21/2016)
• GIST Update (06/20/2016)